New month, and a few new trades.

First, I should note that most of my activity happened in the first half of the month. After that, I tweaked my approach and now have a significantly stricter framework in place when it comes to replacing one holding with another.

As I’m 100% invested right now, the focus is clear: avoid overtrading and don’t switch one high-quality long-term compounder for another just because of a recent dip.

The month itself was largely driven by the Iran war and the effective closure of the Strait of Hormuz. But in my own portfolio, I didn’t try to predict the next tweet from Donald Trump. Instead, I focused on picking up high-quality companies at a discount.

On March 2, I mainly added to the e-commerce side of my portfolio, increasing positions in MercadoLibre and Sea Limited after both stocks sold off quite significantly.

Sea reported a strong quarter on the top line and continues to take market share, but profitability remains a concern. For me, however, market penetration is the key objective at this stage. Margins are a nice-to-have for now. MercadoLibre dropped below $1,700, largely driven by geopolitical noise rather than anything business-related.

After that, things stayed relatively quiet until mid-month, when I made a few bigger moves. I sold my Netflix position, along with some fintech exposure, and redeployed that capital into broader asset managers that were caught up in the private credit selloff without being directly exposed: Brookfield and BlackRock.

I’ve already gone into detail on both buys and the Netflix sale in previous posts.

Around the same time, I also rotated my Visa position into Adyen. There are a few reasons behind that move which I’ll break down separately, but at its core it was a choice between “a bit more safety” and “safety plus stronger growth with European exposure.”

Into the second half of the month, the strategy became even clearer: double down on the most compelling opportunities. Risk/reward setups I’d almost call no-brainers.

I honestly didn’t expect to get another chance to buy Meta below $550 or Microsoft below $370. But when the opportunity presented itself, I took it. Both were already my largest positions going into the month, and they’ve only grown further.

The final addition, which I had been waiting on for a while and stayed disciplined for, was Airbus. I explained my reasoning a few weeks ago, but to sum it up, this was a classic case of short-term geopolitical noise overshadowing long-term quality. Airbus is a high-quality business with a backlog stretching years into the future and only one real competitor, which has its own well-documented issues.

Overall, I’m very happy with how the portfolio is positioned. The Iran war didn’t help performance, but I expect those pressures to ease sooner rather than later.

March Performance: -9%

Performance since inception: -5%

$META (+2,51%)
$MSFT (+1,38%)
$AMZN (+3,03%)
$MELI (+0,95%)
$NVDA (+4,29%)
$BN (-0,05%)
$AIR (-0,09%)
$NOW (+4,85%)
$BLK (-1,06%)
$ADYEN (+0,26%)
$CSU (-3,62%)
$ZETA (+2,19%)
$SE (+2,24%)
$UBER (-0,08%)
$ORCL (-3,27%)

Hello everyone,

Hope you’re all doing well!

After doing some research and reviewing my portfolio, I’ve decided to close a few small positions and open a new position in $ADYEN (+0,26%)

For those who might not be familiar, Adyen is a Dutch payment technology company that provides a unified platform for businesses to accept payments online, in-app, and in physical stores. The technology handles everything from payment processing and risk management to acquiring and reporting, all through one integrated system — which makes it attractive for both large global brands and fast-growing platforms.

What really appealed to me is the calibre of companies that rely on Adyen’s platform. Some prominent global customers include $UBER (-0,08%) , $SPOT (+0,57%) , $MSFT (+1,38%) , $EBAY (-5,62%) and $HM B (-0,7%) — all using $ADYEN (+0,26%) to streamline their payments infrastructure across markets.

Over the past few years, the stock price has been quite the rollercoaster, with significant volatility reflecting broader market trends as well as shifts in the payments landscape. That said, I believe the long-term growth opportunities remain strong. As digital payments continue to expand globally and more merchants look to unified payment solutions, Adyen appears well-positioned to benefit from this trend.

Given the company’s fundamentals and growth potential, I think there’s a nice run ahead toward €1,700, and I’d really like to be along for that journey.

Curious to hear your thoughts — what do you think about Adyen as an investment? Do you believe the company is well positioned for future growth, or are there other players in the market that you think might outperform it?

Looking forward to your insights!

Cheers! 🚀

Trump Meets Putin in Alaska – A Meaningless PR Stunt?

Finally, after weeks of speculation, President Trump has arrived in Alaska to supposedly discuss how to end the war in Ukraine. This is the first face-to-face meeting in several years for the two presidents.

Trump warned of “very severe consequences” if a ceasefire can’t be reached – whatever that’s supposed to mean. Hopefully, it has nothing to do with the ballistic submarines stationed near Russia after Trump and a Russian official engaged in a verbal sparring match on social media. Let’s see where this goes.

UnitedHealth – The Stock Has Found Its Savior

Berkshire Hathaway sold shares in Apple and added to a new, very attractively valued position: UnitedHealth Group. Warren Buffett is known to buy when others are fearful, and speculation surrounded his latest pick until it was finally announced yesterday.

I can gladly say that I’m apparently not the only one who sees great potential in the unloved giant. The company has faced major headwinds – including the vicious and brutal killing of its CEO, higher medical costs, and controversies over its business practices. However, let’s not forget: UnitedHealth is the 9th-largest employer in the U.S. and the largest health insurer worldwide. 1 in 6 Americans is covered by UnitedHealth.

Warren Buffett finally gave the stock the spark it so badly deserved. UnitedHealth is a great company that – and quote me on this – will climb back to all-time highs. The insurer has a massive moat, strong fundamentals, and generates cash like King Midas. This is one of the positions in my portfolio I’m least worried about. I’ll let it sit there and take profits in two years.

Dlocal vs. Adyen – I Suppose I Chose Correctly

Investor’s reaction to the earnings of these two fintech companies couldn’t have been more different. One stock fell 20% after the report, while the other jumped more than 40%. Dlocal and Adyen both operate as international payment processors – Dlocal primarily in South America and other emerging markets, and Adyen across global markets.

Dlocal raised its guidance, beat expectations, and impressed with excellent execution, while Adyen struck a cautious tone and predicted a soft outlook. I find both companies highly interesting, but I decided to invest in Dlocal a few weeks ago due to its superior expansion potential, more attractive valuation, and strong leadership.

I feel proven right after the recent reports, though I wouldn’t be opposed to opening a position in Adyen if the stock drops further.

$UNH (-0,07%)
$BRK.A (-0,66%)
$BRK.B (-0,57%)
$AAPL (-0,73%)
$DLO
$ADYEN (+0,26%)
$ADYEN (+0,26%)
$BRNT (-1,4%)
$CRUD (-1,58%)